MYOCARDIAL-INFARCTION AFTER CHEMOTHERAPY FOR TESTICULAR TERATOMA

被引:3
作者
BISSETT, D
KAYE, SB
机构
关键词
D O I
10.1093/oxfordjournals.annonc.a058529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:432 / 432
页数:1
相关论文
共 5 条
[1]   LONG-TERM SEQUELAE OF TREATMENT FOR TESTICULAR GERM-CELL TUMORS [J].
BISSETT, D ;
KUNKELER, L ;
ZWANENBURG, L ;
PAUL, J ;
GRAY, C ;
SWAN, IRC ;
KERR, DJ ;
KAYE, SB .
BRITISH JOURNAL OF CANCER, 1990, 62 (04) :655-659
[2]   THE LATE EFFECTS OF GERM-CELL TUMOR-CHEMOTHERAPY - MORE DATA ARE NEEDED [J].
BOSL, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) :1375-1376
[3]   ONDANSETRON IS NOT ASSOCIATED WITH VASCULAR ADVERSE EVENTS, THROMBOCYTOPENIA OR RENAL-FAILURE [J].
CASTLE, WM ;
CUNNINGHAM, K ;
KANAREK, BB .
ANNALS OF ONCOLOGY, 1992, 3 (09) :773-774
[4]   ACUTE VASCULAR ISCHEMIC EVENTS AFTER CISPLATIN-BASED COMBINATION CHEMOTHERAPY FOR GERM-CELL TUMORS OF THE TESTIS [J].
DOLL, DC ;
LIST, AF ;
GRECO, FA ;
HAINSWORTH, JD ;
HANDE, KR ;
JOHNSON, DH .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (01) :48-51
[5]  
WALL JG, 1989, AM J MED, V87, P501